"Hyperplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Descriptor ID |
D006965
|
| MeSH Number(s) |
C23.550.444
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperplasia".
Below are MeSH descriptors whose meaning is more specific than "Hyperplasia".
This graph shows the total number of publications written about "Hyperplasia" by people in this website by year, and whether "Hyperplasia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 9 | 9 |
| 1997 | 1 | 4 | 5 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 10 | 10 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 7 | 7 |
| 2003 | 1 | 4 | 5 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 5 | 5 |
| 2007 | 1 | 5 | 6 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 5 | 5 |
| 2011 | 1 | 6 | 7 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 5 | 6 |
| 2014 | 0 | 3 | 3 |
| 2015 | 0 | 6 | 6 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 6 | 6 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperplasia" by people in Profiles.
-
Contribution of NLRP3-GSDMD axis to PDGF-BB-induced vascular smooth muscle cell phenotypic transition. Am J Physiol Cell Physiol. 2025 Aug 01; 329(2):C682-C698.
-
Bismuth-infused perivascular wrap facilitates delivery of mesenchymal stem cells and attenuation of neointimal hyperplasia in rat arteriovenous fistulas. Biomater Adv. 2025 Jan; 166:214052.
-
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024 Apr 08; 42(4):605-622.e11.
-
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol. 2024 Apr; 31(4):2224-2230.
-
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol. 2023 12; 36(12):100326.
-
Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun Polymeric Scaffold Inhibits Neointimal Hyperplasia Following Arteriovenous Fistula Formation in a Rat Model of Chronic Kidney Disease. Adv Healthc Mater. 2023 10; 12(26):e2300960.
-
Basaloid Squamous Cell Carcinomas of the Thymus With Prominent B-Cell Lymphoid Hyperplasia: A Clinicopathologic and Immunohistochemical Study of 10 Cases. Am J Surg Pathol. 2023 09 01; 47(9):1039-1044.
-
Liver focal nodular hyperplasia next to giant haemangioma. Dig Liver Dis. 2023 06; 55(6):823.
-
Severe Obesity Associated With Pituitary Corticotroph Hyperplasia and Neoplasia. Endocr Pract. 2023 Jun; 29(6):471-477.
-
A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal Adenocarcinoma. Dis Esophagus. 2023 Feb 24; 36(3).